News Releases

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2023 financial results on Thursday, April...

Resources focus on children’s wider circle of care by supporting parents and caregivers in communicating with providers, through videos, interactive role-playing, digital storybooks, printable...

New capabilities include personalized patient access to Quest's national network of 2,100 patient service centers and 5,000 mobile and at-home phlebotomists, to support patient-compliant pre- and...

New Panels Aimed at the Millions of Americans Still Suffering From COVID-19 Side Effects SECAUCUS, N.J., March 21, 2023 /PRNewswire/ -- The consumer-initiated testing business from the leader in...

Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of select assets of Northern...

Updates 2023-26 compound annual growth rate (CAGR): Revenues expected to grow at mid single-digit rate; adjusted diluted earnings per share (EPS)* expected to grow at high single-digit rate...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors elected James E. Davis, the company's Chief Executive...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Tower Health, a regional integrated healthcare system in Pennsylvania, are teaming up to enhance...

Goal to serve NewYork-Presbyterian's providers and patients in the greater New York region and beyond SECAUCUS, N.J. and NEW YORK, Feb. 14, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on...

Fourth quarter revenues of $2.33 billion, down 15.0% from 2021 Fourth quarter reported diluted earnings per share ("EPS") of $0.87, down 72.1% from 2021; and adjusted diluted EPS of $1.98, down...

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the Company's Board of Directors has authorized a 7.6% increase in its...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2023...

Quest Launches the First Annual "Know Your Health" Survey to Inspire Americans to Take Control of Their Well-being in 2023 SECAUCUS, N.J., Jan. 23, 2023 /PRNewswire/ -- The consumer-initiated...

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2022 financial results on...

Marks 1-Year since Quest Diagnostics Announced Plans to Acquire Pack Health to Extend Digital Engagement and Coaching Services to Health Plans, Employers and Life Sciences Companies BIRMINGHAM, Ala.,

Our Media Statement about COVID-19 Testing This is an evolving situation. Please check back to this page periodically for the latest information For more information, members of the media may...

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 41st Annual J.P. Morgan Healthcare...

Analysis of 20 million clinical drug tests performed by Quest Diagnostics over the past decade shows increases in drug mixing and amphetamines use, and highlights the need for drug misuse...

Quest to acquire Northern Light Health's outreach laboratory business and professionally manage nine of its hospital laboratories SECAUCUS, N.J. and BREWER, Maine, Dec. 8, 2022 /PRNewswire/ --...

Quest Diagnostics (NYSE:DGX), the nation's leading provider of diagnostic information services, has been awarded a group purchasing agreement for its laboratory stewardship solution with Premier...

Physicians and patients to benefit from access to Quest's industry-leading test menu and broad health plan relationships in Northeastern Ohio SECAUCUS, N.J. and AKRON, Ohio, Nov. 28, 2022...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.66 per share,...

Quest Diagnostics (NYSE: DGX) has just unveiled three new fitness panels on questhealth.com, designed for athletes of every kind, from weekend warriors to gold medalists. Each fitness test panel...

The recognition program honors companies and nonprofits providing people compelling reasons to care about them and offering inspiration for others to buy in SECAUCUS, N.J., Nov. 2, 2022...

DALLAS, November 1, 2022 — According to the Association of American Medical Colleges, only 8% of medical students and 5% of physicians are Black and African American. In an effort to address...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Jim Davis has succeeded Steve Rusckowski as the CEO and President of Quest...

Healthy Houston Collective includes a multipronged approach to addressing key disparities in the Houston area HOUSTON, Oct. 28, 2022 /PRNewswire/ -- Bread of Life, Inc. announced the launch of the...

Sesame Workshop, the nonprofit educational organization behind Sesame Street which reaches 156 million children across more than 150 countries, and Quest Diagnostics (NYSE: DGX), the world's...

Third quarter revenues of $2.49 billion, down 10.4% from 2021 Third quarter reported diluted earnings per share ("EPS") of $2.17, down 46.0% from 2021; and adjusted diluted EPS of $2.36, down...

Decode Health, a healthcare AI company that enables a partner ecosystem to innovate and solve data challenges involving disease risk, today announced a new phase of its collaboration with Quest...

Quest Diagnostics (NYSE: DGX), the leader in diagnostic testing, unveiled a nationwide campaign, titled "Put Your ___ To The Test." The unexpected, provocative, and fresh campaign empowers...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced Jim Davis, CEO-Elect, has made several organizational changes and leadership...

Analysis of more than 1.1 million test results across the United States suggests more people are living with undiagnosed cancer than before the pandemic, with potential for worse outcomes and...

Transaction to broaden access to innovative, quality diagnostic information services powering affordable care in Ohio SECAUCUS, N.J., and AKRON, Ohio, Oct. 5, 2022 /PRNewswire/ -- Quest...

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2022 financial results on Thursday, October...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Lee Health, Southwest Florida's primary community-owned health system, are teaming up to enhance...

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 20th Annual Global...

First lab-developed test specifically designed to detect Monkeypox virus DNA to receive emergency use authorization during the monkeypox public health emergency SECAUCUS, N.J., Sept. 7, 2022...

New test panel follows a Quest Diagnostics Health Trends® study with the CDC that revealed less than half of pregnant people are screened for hepatitis C as recommended under guidelines SECAUCUS,...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.66 per share,...

DALLAS, August 5, 2022 — The American Heart Association, the world’s leading nonprofit organization focused on longer, healthier lives for all, is committed to addressing the lack of diversity...

Better healthcare among America's large and growing Hispanic community is receiving an important, new level of support from Quest Diagnostics, the world's leading provider of diagnostic...

SECAUCUS, N.J., (August 3, 2022) - Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been recognized by Forbes as one of America’s...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been named to the 2022 Disability Equality Index® (DEI) Best Places to Work for...

Analysis of nearly 23 million lab tests finds only 1 in 3 patients with latent tuberculosis were also tested for chronic hepatitis B, despite similar risk factors in patients Findings heighten...

Second quarter revenues of $2.45 billion, down 3.8% from 2021 Second quarter reported diluted earnings per share ("EPS") of $1.96, down 60.5% from 2021; and adjusted diluted EPS of $2.36, down...

PHILADELPHIA & SECAUCUS, N.J.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced it is collaborating with Quest Diagnostics (NYSE: DGX) to provide access to quality, COVID-19 molecular testing...

Company to be able to perform approximately 30,000 tests a week by the end of July, supplementing public health response Physicians can order the novel Quest Diagnostics lab test beginning today...

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today released its 2021 Corporate Responsibility Report. The report provides information regarding...